beta-cyclodextrin-benzaldehyde has been researched along with Sarcoma, Epithelioid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimaki, M; Kishimoto, C; Kurokawa, M; Kuroki, Y; Niwayama, S; Ochiai, H; Tazawa, K | 1 |
1 other study(ies) available for beta-cyclodextrin-benzaldehyde and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Augmentation of murine lymphokine-activated killer cell cytotoxicity by beta-cyclodextrin-benzaldehyde.
Topics: Animals; Benzaldehydes; beta-Cyclodextrins; Cyclodextrins; Cytotoxicity, Immunologic; Drug Synergism; Flow Cytometry; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Sarcoma | 1991 |